Bilirubin is the end product of heme catabolism formed during a process that involves
oxidation-reduction reactions and conserves iron body stores. Unconjugated …

Extreme neonatal jaundice occurs infrequently but carries a high risk of permanent sequelae
(kernicterus) when it does. Rapid therapeutic intervention has the potential to reduce this …

Concerns of possible genotoxic effects of hyperbilirubinemia and phototherapy were raised
from experimental and observational studies in neonates. This study aimed to assess the …

Although phototherapy was introduced as early as 1950's, the potential biological effects of
bilirubin photoisomers (PI) generated during phototherapy remain unclear. The aim of our …

Aim: To compare a new turquoise (“green”) fluorescent phototherapy lamp (490 nm) with a
conventional blue phototherapy lamp (450 nm) with respect to cytotoxicity and …

For many years, unconjugated bilirubin (UCB) was thought to be a useless waste product of
heme catabolism, with no physiological function, but with potential toxicity. Toxicity resulting …

Jaundice from unconjugated hyperbilirubinemia is arguably the most common reason for
diagnostic and therapeutic interventions in newborn infants. Estimates for usage rates in …

Background Phototherapy is a widely accepted, effective first‐line therapy for neonatal
jaundice. It is traditionally used continuously but intermittent phototherapy has been …

Phototherapy is the most frequently used treatment for the neonatal jaundice. However,
recent papers report that phototherapy increased apoptosis in peripheral mononuclear …

Documentation is scarce on the photobiological effects of photoinitiators present in dental
light curable materials. The aim of this study was to determine cellular effects of the …